📇 Rhumatologue · PARIS CEDEX 15 · (75) · Salarié
Chargement de la fiche…
Chargement de la fiche…
MonRhumato.fr utilise des cookies pour mesurer l'audience (statistiques) et améliorer le site. Aucune donnée de santé identifiable n'est jamais collectée. Politique de confidentialité.
Votre choix est conservé 13 mois (durée max CNIL). Vous pouvez le modifier à tout moment via Préférences cookies.
2 raisons identifiées
Praticien-chercheur
19 articles scientifiques publiés — formation continue solide
Délais de RDV courts dans la région
336.2 rhumatos / 100 000 hab. — département bien doté
✨ Génération du profil synthétique IA en cours…
GHU CUP SITE NECKER ENFANTS MALADES
149 R DE SEVRES, 75743 PARIS CEDEX 15
Secteur de conventionnement non disponible (médecin hospitalier ou non présent dans l'Annuaire santé CNAM des libéraux conventionnés).
Données ANS publiques (Licence Ouverte 2.0) · Enrichissements MonRhumato 100 % opt-in · Toute personne référencée peut demander la suppression ou la rectification.
Lien Doctolib = recherche Google site:doctolib.fr (le 1er résultat est presque toujours le profil correct s'il existe).
Current genomics · 2014
Biomolecules · 2022
Microbial products have been used for the treatment of different diseases for many centuries. The serratiopeptidase enzyme provides a new hope for COVID-19-infected patients. Nowadays, anti-inflammatory drugs are easy to obtain at minimal expenditure from microbial sources. Serratia sp. is identified as one of the most efficient bacteria produced from serratiopeptidase. Screening for new and efficient bacterial strains from different sources has been of interest in recent years. Serratiopeptidase remains the most well-known anti-inflammatory drug of choice. Serratiopeptidase is a cheaper and safer anti-inflammatory drug alternative to NSAIDs. The multifaceted properties of serratiopeptidase may lead towards arthritis, diabetes, cancer and thrombolytic treatments. Existing serratiopeptidase treatments in combination with antibiotics are popular in the treatment of postoperative swelling. Although an exclusive number of serratiopeptidase-producing strains have been derived, there is an urge for new recombinant strains to enhance the production of the enzyme. This review explores the properties of serratiopeptidase, different therapeutic aspects, industrial production, and various analytical techniques used in enzyme recovery. In addition, the review highlights the therapeutic and clinical aspects of the serratiopeptidase enzyme to combat COVID-19-induced respiratory syndrome.
The open rheumatology journal · 2014
Objectives : To compare foot posture in people with and without medial compartment knee osteoarthritis (OA), and to assess association between its abnormalities and medial compartment knee OA. Methods : We compared the foot posture of patients with clinically and radiographically-confirmed medial compartment knee OA and asymptomatic healthy controls using the foot posture index (FPI), navicular height, and the medial arch. Results : We included 100 patients and 80 asymptomatic controls. The mean age of patients was 59 ± 7 (44-76) years and 48 ± 9 (28-60) years in the control (p=0.06). Patients group have more pronated foot for FPI (1.50 ± 2.68 vs 0.72 ± 2.63; p=0.05), more flat foot (42% vs 22%; p=0.03), and less pes cavus than the control group (58% vs 77%; p=0.004). However, there was no significant difference between the groups in the navicular height (3.90 ± 0.85 cm vs 4.00 ± 0.76 cm; p=0.41). In multivariate statistical analysis, after adjusting for age and body mass index, pronated foot in FPI (OR=1.22, 95%IC= [1.06-1.40], p=0.005), and pes cavus (OR=0.32, 95%IC= [0.11-0.93], p=0.03) had a significant correlation with the knee osteoarthritis. Conclusion : Pronated foot posture and flat foot are significantly associated with medial compartment knee osteoarthritis.
Source PubMed · Recherche par auteur (homonymes possibles, vérifier l'affiliation).
European journal of pharmacology · 2025 · Journal Article
N P, M M G, C RR, D P, et al.
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference · 2025 · Journal Article
G A, C G, C J M, B L, et al.
Cureus · 2025 · Case Reports
Ps K, R M, Kanchana K, C S, et al.
Cureus · 2024 · Case Reports
Tiwary T, B V, C R
Cureus · 2024 · Case Reports
C SA, P H, Jayanthi N
Annals of the rheumatic diseases · 2023 · Letter
C SK, Ahmed S, Shenoy V, Menon AR, et al.
Biomolecules · 2022 · Journal Article
Nair SR, C SD
The open rheumatology journal · 2014 · Journal Article
F E A, N K, H A, F L, et al.
Cureus · 2025 · Case Reports
C P, Ann Jose J, Verma G, Priya V L, et al.
Cureus · 2024 · Case Reports
Ramanan A, Balasubramanian V, C R, Sami P
JBJS case connector · 2024 · Case Reports
C A, Raju A, Meleppuram JJ, Nair AV, et al.
Journal of orthopaedic case reports · 2016 · Case Reports
Nekkanti S, C V, Js ST, R R, et al.
Lupus · 2023 · Journal Article
Patil A, Shobha V, Shenoy P, S C, et al.
Cureus · 2019 · Case Reports
Thomas M, Robert A, Kuruvilla N, C U
Current genomics · 2014 · Journal Article
J de AS, C A, P SG, S C
Cureus · 2024 · Case Reports
Ramanan A, Balasubramanian V, C R, Sami P
Journal of orthopaedic case reports · 2016 · Case Reports
Nekkanti S, C V, Js ST, R R, et al.
European journal of pediatrics · 2024 · Journal Article
Yıldız Ç, Küçükali B, C SSB, Şenol PE, et al.
European journal of pediatrics · 2024 · Journal Article
Yıldız Ç, Küçükali B, C SSB, Şenol PE, et al.
Cureus · 2025 · Case Reports
Lakshme I, C A, Senthil N, Pandurangan V
Cureus · 2026 · Case Reports
R S, Nanda M S, Adalarasan S, Subramanian Y, et al.
Journal of orthopaedic case reports · 2016 · Case Reports
Ay GR, D SR, T C, C K, et al.
✨ Profil synthétique
IA · 24/05/2026Le Dr M CARLOS-FELIPE SUAREZ-BOUTROS est un rhumatologue exerçant à Paris. Ses publications sur PubMed couvrent divers sujets, notamment des cas cliniques, le lupus, ainsi que l'utilisation de la corticothérapie. Il a également publié des travaux dans le domaine de la pédiatrie et des soins ambulatoires en lupus (SAPL).
Expertises présumées
Synthèse automatique à partir des sources publiques (HAL, OpenAlex, theses.fr, ClinicalTrials.gov, FAI²R, ANS). Pas une évaluation clinique. Le médecin peut corriger via son compte.